当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 现金流量表

贝瑞基因

(000710)

  

流通市值:29.36亿  总市值:30.93亿
流通股本:3.36亿   总股本:3.54亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金441,228,846.38204,932,500.091,064,649,230.75759,679,533.2
  收到的税费返还182,362.31177,278.853,345,900.073,388,626.12
  收到其他与经营活动有关的现金2,319,694.981,612,923.4427,480,795.414,227,870.38
  经营活动现金流入小计443,730,903.67206,722,702.381,095,475,926.23767,296,029.7
  购买商品、接受劳务支付的现金293,548,897.19175,435,173.56513,576,328.14421,184,452.67
  支付给职工以及为职工支付的现金156,401,698.9576,841,487.36319,962,324.55240,832,669.78
  支付的各项税费25,767,358.357,945,156.3149,833,795.3236,091,944.73
  支付其他与经营活动有关的现金70,272,134.5338,133,334.74141,495,745.5393,769,793.41
  经营活动现金流出小计545,990,089.02298,355,151.971,024,868,193.54791,878,860.59
  经营活动产生的现金流量净额-102,259,185.35-91,632,449.5970,607,732.69-24,582,830.89
二、投资活动产生的现金流量:
  收回投资收到的现金--9,934,868.389,502,364.16
  处置固定资产、无形资产和其他长期资产收回的现金净额6,126,047.856,108,047.8512,066,6806,060,992.23
  投资活动现金流入小计6,126,047.856,108,047.8522,001,548.3815,563,356.39
  购建固定资产、无形资产和其他长期资产支付的现金25,589,719.6713,395,755.9575,683,852.163,345,002.4
  投资支付的现金6,354,056.226,354,056.2212,062,498.076,476,810.29
  投资活动现金流出小计31,943,775.8919,749,812.1787,746,350.1769,821,812.69
  投资活动产生的现金流量净额-25,817,728.04-13,641,764.32-65,744,801.79-54,258,456.3
三、筹资活动产生的现金流量:
  吸收投资收到的现金-30,000,0001,600,0002,020,000
  其中:子公司吸收少数股东投资收到的现金--1,600,000-
  取得借款收到的现金116,048,868.9106,048,868.9182,848,975.65172,848,975.65
  收到其他与筹资活动有关的现金39,000,0009,000,000--
  筹资活动现金流入小计155,048,868.9145,048,868.9184,448,975.65174,868,975.65
  偿还债务支付的现金151,669,660105,240,917.78141,975,571.33133,696,255.68
  分配股利、利润或偿付利息支付的现金2,478,489.741,227,568.344,728,898.783,462,275.21
  支付其他与筹资活动有关的现金18,499,196.649,000,00025,688,064.9814,572,959.64
  筹资活动现金流出小计172,647,346.38115,468,486.12172,392,535.09151,731,490.53
  筹资活动产生的现金流量净额-17,598,477.4829,580,382.7812,056,440.5623,137,485.12
四、汇率变动对现金及现金等价物的影响-3,349,260.9-2,225,966.99-3,027,599.87-2,058,048.65
五、现金及现金等价物净增加额-149,024,651.77-77,919,798.1213,891,771.59-57,761,850.72
  加:期初现金及现金等价物余额372,204,585.73372,204,585.73358,312,814.14358,312,814.14
  期末现金及现金等价物余额223,179,933.96294,284,787.61372,204,585.73300,550,963.42
补充资料:
  净利润-43,116,696.55--196,294,138.02-
  资产减值准备---674,124.35-
  固定资产和投资性房地产折旧28,607,172.1-59,359,691.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,607,172.1-59,359,691.09-
  无形资产摊销4,040,321.53-4,651,985.12-
  长期待摊费用摊销7,356,383.31-13,596,012.38-
  处置固定资产、无形资产和其他长期资产的损失1,884,589.29--4,998,568.37-
  固定资产报废损失-3,266.9-247,351.76-
  公允价值变动损失--2,841,154.08-
  财务费用1,757,318.99-9,405,782.45-
  投资损失645,647.25-3,537,842.81-
  递延所得税1,279,849.7--5,320,026.57-
  其中:递延所得税资产减少2,193,955.01--6,347,290.87-
    递延所得税负债增加-914,105.31-1,027,264.3-
  存货的减少465,400.04-18,825,960.62-
  经营性应收项目的减少-51,233,178.89-63,204,184.84-
  经营性应付项目的增加-84,381,278.2--29,678,540.96-
  其他---2,099,963.83-
  现金的期末余额223,179,933.96-372,204,585.73-
  减:现金的期初余额372,204,585.73-358,312,814.14-
  现金及现金等价物的净增加额-149,024,651.77-13,891,771.59-
公告日期2026-08-242026-04-302026-04-292025-10-31
审计意见(境内)标准无保留意见
TOP↑